SPIMACO's strategy was based on developing business relationship with most of the existing players in the pharmaceutical market. This was aimed at capitalizing on their strengths, and specialization. At the same time this gave SPIMACO the chance to focus on developing its own strengths in Manufacturing, Registration, Sales and Marketing. These comprehensive advantages with the strong image in the minds of the medical practitioners provide existing and new partners with distinctive advantages; they cannot access individually or through other parties. SPIMACO employed various alliance and cooperation models as discussed below.

Manufacturing and Institutions Marketing Deals:
Most of SPIMACO earlier deals were structured so that SPIMACO manufactures products for multinationals for all market segments. SPIMACO would take the role of sales and marketing (together with the licensors) at the MOH and other government institutions. Private market products would be manufactured by SPIMACO and sold to the licensor's distributors, while the licensor's local Scientific Office handles the marketing activities. The successful results of this model attracted more multinationals to new agreements with SPIMACO.

Co-Marketing:
SPIMACO's outstanding success in the private market attracted some multinationals to grant SPIMACO, the marketing rights to develop second brands for their leading innovative brands. SPIMACO launched LORINE, licensed from Schering Plough as a second brand to Schering Plough's leading non-sedating anti-allergic Claritin. GSK licensed SPIMACO KLAVOX a second brand for Augmentin, the leading product in Saudi Arabia.

Full Marketing Rights:
Vifor International has granted SPIMACO full marketing rights for its iron product (Ferrum). The product is branded FEROSE & FEROSAC I.V. and was launched in 1997 becoming successfully the No. 1 leading product of the plain iron preparations only five months after launch.

Distribution:
SPIMACO has its own distribution network under its subsidiary ARAC. ARAC is well equipped with expertise and an effective transportation system to meet on time demand of pharmacies in the private market. ARAC caters the requirement of even remote areas very effectively.

SPIMACO Products :
SPIMACO manufactures & markets more than 150 products in various markets. SPIMACO portfolio is widespread and balanced. SPIMACO strategy is to continue providing its Saudi and Regional customers with high quality products.